Myocardial Effects of Erythropoietin During Resuscitation from Cardiac Arrest

心脏骤停复苏期间促红细胞生成素对心肌的影响

基本信息

  • 批准号:
    8262624
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Sudden cardiac arrest is a problem of public health magnitude affecting 330,000 individuals annually in the United States with an averaged survival rate of only 7%. Return of cardiac activity requires reperfusion of ischemic tissues with oxygenated blood. Yet, reperfusion concomitantly activates multiple pathogenic mecha- nisms, collectively known as "reperfusion injury." Current resuscitation methods do not include interventions that could ameliorate such injury. Yet, the discovery that erythropoietin activates potent cell protective mecha- nisms (many of which converge on mitochondria) may provide the means to ameliorate such injury during car- diac arrest and to establish a novel paradigm for cardiac resuscitation. We have reported in a rat model of ventricular fibrillation (VF) and closed-chest resuscitation that erythropoietin elicits favorable myocardial effects that result in hemodynamically more effective chest compression and im- proved post-resuscitation hemodynamic function. Moreover, in a recently clinical trial conducted in collabora- tion with colleagues in Slovenia, administration of erythropoietin was associated with increased rate of initial resuscitation and increased rate of survival to hospital discharge. We hypothesize that administration of erythropoietin rapidly activates non-genomic cell protective mechanisms prompting mitochondria to resist reperfusion injury and remain bioenergetically functional, resulting during car- diac resuscitation in: 1) preservation of left ventricular myocardial distensibility enabling hemodynamically more effective CPR and higher resuscitation rates and 2) better post-resuscitation myocardial function yielding - in conjunction with higher resuscitation rates - higher rates of neurologically intact survival. We propose to use first an open-chest pig model of VF and extracorporeal circulation allowing precise control of coronary perfusion pressure and direct access to the myocardium to investigate: (1) whether erythropoietin prevents deterioration of mitochondrial bioenergetic function enabling preservation of left ventricular compli- ance during VF and preservation of left ventricular function after return of spontaneous circulation, (2) whether these effects are mediated through activation and mitochondrial translocation of PKC5 and Akt leading to pres- ervation of mitochondrial respiration, and (3) whether the effects of erythropoietin vary contingent on coronary blood flow, given the inconsistent quality of manual CPR and the increasing availability of hemodynamically more potent CPR methods. We will then use a pig model of VF and closed-chest resuscitation to examine the effects of erythropoietin in the presence or absence of concomitant administration of epinephrine on the hemo- dynamic efficacy of chest compression, initial resuscitation, post-resuscitation myocardial function, and 72-hour survival with intact neurological function. Demonstration that erythropoietin preserves mitochondrial bioenergetic function leading to functional myocar- dial benefits for resuscitation would be novel and facilitate the planning and conduct of additional clinical trials, and eventual clinical implementation. PUBLIC HEALTH RELEVANCE: Nearly 330,000 individuals suffer an episode of sudden cardiac arrest every year in the United States. Many of these individual are Veterans given the high prevalence of coronary artery disease and underling risk factors such as smoking, hypertension, high cholesterol, and diabetes mellitus. Current resuscitation techniques fail to promote neurologically intact survival in more than 7% of these individuals. New and more effective treatments for sudden cardiac arrest that will enable a substantially higher number of individuals to survive without organ dysfunction are urgently needed. This application will examine one approach for improving resuscitation from cardiac arrest by administration of erythropoietin during cardiopulmonary resuscitation. Erythropoietin is a naturally occurring hormone that has been shown in recent studies to help the heart and other organs resist the injury caused by lack of blood flow. Successful development of this new approach to cardiac resuscitation could lead to thousands of lives saved every year in the United States and many more worldwide.
描述(由申请人提供): 心脏骤停是一个严重的公共卫生问题,在美国每年影响33万人,平均存活率仅为7%。心脏活动的恢复需要用含氧血液对缺血组织进行再灌注。然而,再灌注同时激活多种致病机制,统称为“再灌注损伤”。“目前的复苏方法不包括可以改善这种损伤的干预措施。然而,发现促红细胞生成素激活有效的细胞保护机制(其中许多集中在线粒体上)可能提供改善心脏骤停期间这种损伤的方法,并建立心脏复苏的新范例。我们在大鼠心室颤动(VF)和闭胸复苏模型中报道了促红细胞生成素(EPO)对心肌的有利作用,导致血流动力学上更有效的胸部按压,并改善复苏后的血流动力学功能。此外,在最近与斯洛文尼亚同事合作进行的一项临床试验中,促红细胞生成素的给药与初始复苏率增加和出院存活率增加相关。我们假设,促红细胞生成素的给药快速激活非基因组细胞保护机制,促使线粒体抵抗再灌注损伤并保持生物能量功能,导致心脏复苏期间:1)保持左心室心肌扩张性,使血液动力学更有效的CPR和更高的复苏率,2)更好的复苏后心肌功能,与更高的复苏率相结合-更高的神经系统完整存活率。我们建议首先使用VF和体外循环的开胸猪模型,允许精确控制冠状动脉灌注压并直接进入心肌,以研究:(1)促红细胞生成素是否防止线粒体生物能量功能的恶化,从而能够在VF期间保持左心室顺应性和在自主循环恢复后保持左心室功能,(2)这些作用是否通过PKC 5和Akt的激活和线粒体易位介导,导致线粒体呼吸的维持,和(3)促红细胞生成素的作用是否随冠状动脉血流而变化,考虑到手动CPR的质量不一致和血流动力学上更有效的CPR方法的日益可用性。然后,我们将使用VF和闭胸复苏的猪模型来检查促红细胞生成素在存在或不存在肾上腺素伴随给药的情况下对胸部按压的血液动力学功效、初始复苏、复苏后心肌功能和具有完整神经功能的72小时存活率的影响。证明促红细胞生成素保留线粒体生物能量功能,导致功能性心肌复苏益处,这将是新颖的,并有助于计划和实施额外的临床试验,以及最终的临床实施。 公共卫生关系: 在美国,每年有近33万人遭受心脏骤停的发作。这些人中的许多人是退伍军人,因为冠状动脉疾病的患病率很高,而且存在吸烟、高血压、高胆固醇和糖尿病等潜在风险因素。目前的复苏技术未能促进超过7%的这些人的神经完整的生存。迫切需要新的和更有效的治疗心脏骤停的方法,使更多的人能够在没有器官功能障碍的情况下生存。本申请将研究在心肺复苏期间通过给予促红细胞生成素来改善心脏骤停复苏的一种方法。促红细胞生成素是一种天然存在的激素,最近的研究表明,它可以帮助心脏和其他器官抵抗因缺乏血流而造成的损伤。这种新的心脏复苏方法的成功开发可能会导致美国每年挽救数千人的生命,并在全世界范围内挽救更多的生命。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Raul Jaime Gazmuri其他文献

Raul Jaime Gazmuri的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Raul Jaime Gazmuri', 18)}}的其他基金

Attenuation of Reperfusion Injury by Gliflozins During Cardiac Arrest Leading to Improved Post-Resuscitation Myocardial Function and Survival
格列净减轻心脏骤停期间的再灌注损伤,改善复苏后心肌功能和生存率
  • 批准号:
    10366212
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Attenuation of Reperfusion Injury by Gliflozins During Cardiac Arrest Leading to Improved Post-Resuscitation Myocardial Function and Survival
格列净减轻心脏骤停期间的再灌注损伤,改善复苏后心肌功能和生存率
  • 批准号:
    10531884
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Cyclophilin-D: A Regulator of Mitochondrial Oxidative Phosphorylation
亲环蛋白-D:线粒体氧化磷酸化的调节剂
  • 批准号:
    10265322
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Myocardial Effects of Erythropoietin During Resuscitation from Cardiac Arrest
心脏骤停复苏期间促红细胞生成素对心肌的影响
  • 批准号:
    7931837
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Myocardial Effects of Erythropoietin During Resuscitation from Cardiac Arrest
心脏骤停复苏期间促红细胞生成素对心肌的影响
  • 批准号:
    8394593
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Myocardial Effects of Erythropoietin During Resuscitation from Cardiac Arrest
心脏骤停复苏期间促红细胞生成素对心肌的影响
  • 批准号:
    8195595
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
MYOCARDIAL PROTECTION BY NHE-1 INHIBITION
NHE-1 抑制对心肌的保护
  • 批准号:
    6922874
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
MYOCARDIAL PROTECTION BY NHE-1 INHIBITION
NHE-1 抑制对心肌的保护
  • 批准号:
    6560274
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
MYOCARDIAL PROTECTION BY NHE-1 INHIBITION
NHE-1 抑制对心肌的保护
  • 批准号:
    6662580
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
MYOCARDIAL PROTECTION BY NHE-1 INHIBITION
NHE-1 抑制对心肌的保护
  • 批准号:
    6782615
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了